In two other instances, bone specimens from sites presumed to have had a complete response to therapy (measured by the absence of FDG uptake on PET/CT imaging) were later determined to be >30% tumor-positive with a Ki-67 score of 10% suggesting moderately proliferating disease. This evidence concerns the gene MKI67 and neoplasm.